Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
| ▸ | GRM5 | P41594 | 12/20 | 0.40 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CASP3 | P42574 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6446086 | 0.81 | MAOA (0.49) | MMP2MMP9GRM5APP | |
| SCHEMBL21570566 | 0.75 | AR (0.49) | MMP2MMP9GRM5MAPTFFAR1 | |
| SCHEMBL1584832 | 0.75 | FFAR1 (0.43) | GRM5FFAR1 | |
| SCHEMBL1584830 | 0.75 | FFAR1 (0.43) | GRM5FFAR1 | |
| SCHEMBL484011 | 0.66 | KMT2A (0.44) | MAPTFFAR1KDM4EMEN1KMT2A | |
| SCHEMBL8526124 | 0.66 | KMT2A (0.44) | MAPTFFAR1KDM4EMEN1LMNA | |
| SCHEMBL2114741 | 0.65 | APP (0.92) | GRM5APPMAPTFFAR1KDM4E | |
| SCHEMBL23623855 | 0.62 | CYP19A1 (0.44) | MAPTKDM4EKMT2ASMN1; SMN2 | |
| SCHEMBL3535701 | 0.62 | MAOA (0.54) | MAPTLMNAKMT2ASMN1; SMN2 | |
| SCHEMBL15515642 | 0.62 | KMT2A (0.44) | MAPTFFAR1MEN1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1608369-A2 | USE OF ORGANIC COMPOUNDS FOR IMMUNOPOTENTIATION | CHIRON CORPORATION (US) | 2005-12-28 | — | — | EP | disclosed |
| WO-2004087153-A2 | USE OF ORGANIC COMPOUNDS FOR IMMUNOPOTENTIATION | CHIRON CORPORATION (US) | 2004-10-14 | — | — | WO | disclosed |